$24.920
-0.414 (-1.66%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.06, suggesting NAMS is Strong sell.
NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 27.15, while NewAmsterdam Pharma Company NV (NAMS) share price is $—, making it Sell.
NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 30.07, while NewAmsterdam Pharma Company NV (NAMS) share price is $—, making it Sell.
Technical Analysis for NAMS
AI Technical NAMSAs of 2026-08-29, the technical board for NewAmsterdam Pharma Company NV (NAMS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $24.92 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 31.406, MACD stands at -1.056 (Sell), Stochastic %K stands at 9.374 (Buy), Stochastic %D stands at 18.259 and CCI stands at -223.785 (Buy).
NAMS trades below the 60-day SMA (30.07) and below the 200-day SMA (32.74). Immediate resistance sits at Classic R1 28.82, then R2 30.77. Support sits at Classic S1 24.86, then S2 22.85.
NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level
NewAmsterdam Pharma Company NV (NAMS) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 31.406 |
| STOCHk_14_3_3 | 9.374 |
| STOCHd_14_3_3 | 18.259 |
| CCI_20 | -223.785 |
| AO_5_34 | -2.108 |
| MOM_10 | -2.330 |
| MACD_12_26_9 | -1.056 |
NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI_14) is 31.406, creating a Neutral signal.
NewAmsterdam Pharma Company NV (NAMS) Stochastic %K is 9.374, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) Stochastic %D is 18.259, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) CCI_20 is -223.785, creating a Buy signal.
NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator (AO) is -2.108, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Momentum (MOM) is -2.330, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Moving Average Convergence Divergence (MACD) is -1.056, creating a Sell signal.
NewAmsterdam Pharma Company NV (NAMS) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 26.070 | Sell |
| MA_10 | 26.872 | Sell |
| MA_20 | 27.150 | Sell |
| MA_60 | 30.069 | Sell |
| MA_200 | 32.743 | Sell |
| MA_250 | 32.654 | Sell |
NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 26.070, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 26.872, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 27.150, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 30.069, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 32.743, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 32.654, while NewAmsterdam Pharma Company NV (NAMS) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.